The Edinburgh Molecular Mechanisms Cluster
The Edinburgh Molecular Mechanisms Cluster
批准号:
MR/Y030877/1
负责人:
John Kenneth Baillie
金额:
$541.62万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2024
资助国家:
英国
项目状态:
未结题
起止时间:
2024 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Modern medicine enables doctors to treat diseases better than ever before, but there is still much more to learn. Human genetics can help. Tens of thousands of genes have been found underlying a number of devastating diseases, from Alzheimer's to COVID-19. These genes sometimes gives us clues that can help everyone with that disease, not just people who have particular genes. We have already shown that this works: we found a gene in severe COVID-19 that led directly to a new and effective treatment.To make the jump from disease gene to treatment, we need better information about what disease genes actually do in the right cell types from the human body, and in conditions that mimic real disease. Our plan is to set up a system to study how genes work in hard-to-get cell types and conditions. We will use real human samples, donated by our patients, that would otherwise be discarded. We are already able to do this with samples of brain, lung, and skin. To mimic the complicated environment inside a patient even more closely, we will then add a range of different chemicals to the samples and see what happens to the genes, and the cells. We will share our data quickly with scientists across the world to move medical research and drug development forward. We will build a community of doctors and scientists to help guide us towards the most important and useful gene functions. Together, our system will give much more information about genes and how they work to make disease better or worse, giving us a chance to find better and more accurate treatments to help more patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ISARIC CCP activation for acute hepatitis of unknown cause
-
批准号:MR/X010252/1
-
项目类别:Research Grant
-
资助金额:$126.14万
-
财政年份:2022
-
负责人:John Kenneth Baillie
-
依托单位:
Interim support for ISARIC4C Clinical Characterisation Protocol (CCP) activation for acute severe hepatitis in children of unknown cause
-
批准号:MC_PC_22004
-
项目类别:Intramural
-
资助金额:$9.46万
-
财政年份:2022
-
负责人:John Kenneth Baillie
-
依托单位:
ISARIC - Coronavirus Clinical Characterisation Consortium (ISARIC-4C)
-
批准号:MC_PC_19059
-
项目类别:Intramural
-
资助金额:$625.5万
-
财政年份:2020
-
负责人:John Kenneth Baillie
-
依托单位:
ISARIC - Coronavirus Clinical Characterisation Consortium (ISARIC-4C)
-
批准号:MC_PC_19025
-
项目类别:Intramural
-
资助金额:$9.55万
-
财政年份:2020
-
负责人:John Kenneth Baillie
-
依托单位:
COVID-19 GenOMICC-GENOMICS ENGLAND PARTNERSHIP
-
批准号:MC_PC_20004
-
项目类别:Intramural
-
资助金额:$191.13万
-
财政年份:2020
-
负责人:John Kenneth Baillie
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Kidney injury molecular(KIM-1)介导肾小管上皮细胞自噬在糖尿病肾病肾间质纤维化中的作用
-
批准号:81300605
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:唐琳
-
依托单位:
Molecular Plant
-
批准号:31224801
-
项目类别:专项基金项目
-
资助金额:20.0万元
-
批准年份:2012
-
负责人:黄健秋
-
依托单位:
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
-
批准号:31070748
-
项目类别:面上项目
-
资助金额:34.0万元
-
批准年份:2010
-
负责人:Christine Nardini
-
依托单位:
Molecular Plant
-
批准号:31024802
-
项目类别:专项基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:陈晓亚
-
依托单位:
Cellular & Molecular Immunology
-
批准号:30824806
-
项目类别:专项基金项目
-
资助金额:20.0万元
-
批准年份:2008
-
负责人:魏海明
-
依托单位: